Page last updated: 2024-08-23

simvastatin and Peripheral Nerve Diseases

simvastatin has been researched along with Peripheral Nerve Diseases in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (25.00)	18.2507
2000's	3 (37.50)	29.6817
2010's	1 (12.50)	24.3611
2020's	2 (25.00)	2.80

Authors

Authors	Studies
Aizawa, F; Chuma, M; Fujino, H; Fukushima, K; Goda, M; Hamano, H; Ishizawa, K; Izawa-Ishizawa, Y; Kawashiri, T; Kobayashi, D; Koyama, T; Miyata, K; Naito, Y; Niimura, T; Okada, N; Shimazoe, T; Takechi, K; Ushio, S; Yagi, K; Zamami, Y	1
Al-Gareeb, AI; Al-Kuraishy, HM; Al-Naimi, MS; Hussien, NR; Rasheed, HA	1
Hammer, HS; Khalaf, S; Kroetz, DL; Mortensen, C; Nielsen, F; Poetz, O; Rodriguez-Antona, C; Stage, TB; Steffensen, V; Svenningsen, ÅF; Xiong, C	1
Leoh, TH; Lo, YL; Loh, LM; Tan, CE	1
Armitage, J; Collins, R; Parish, S; Peto, R; Sleight, P	1
Clemen, CS; Dodel, R; Klockgether, T; Lütjohann, D; Spottke, EA; Urbach, H; von Bergmann, K	1
Halpern, JP; McLeod, JG; Peiris, O; Phan, T; Pollard, JD; Rohan, A	1
Wehmeier, T; Ziajka, PE	1

Reviews

2 review(s) available for simvastatin and Peripheral Nerve Diseases

Article	Year
Statins an oft-prescribed drug is implicated in peripheral neuropathy: The time to know more. JPMA. The Journal of the Pakistan Medical Association, 2019, Volume: 69(Suppl 3), Issue:8 Topics: Atorvastatin; Drug Interactions; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Peripheral Nervous System Diseases; Risk Factors; Simvastatin	2019
Peripheral neuropathy and lipid-lowering therapy. Southern medical journal, 1998, Volume: 91, Issue:7 Topics: Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Naphthalenes; Niacin; Peripheral Nervous System Diseases; Pravastatin; Pyrroles; Simvastatin	1998

Trials

1 trial(s) available for simvastatin and Peripheral Nerve Diseases

Article	Year
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet (London, England), 2004, Mar-06, Volume: 363, Issue:9411 Topics: Adult; Aged; Anticholesteremic Agents; Arterial Occlusive Diseases; Brain Ischemia; Cerebrovascular Disorders; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Female; Humans; Incidence; Male; Middle Aged; Peripheral Nervous System Diseases; Placebos; Simvastatin; Stroke; Treatment Outcome	2004

Article

Year

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.

Lancet (London, England), 2004, Mar-06, Volume: 363, Issue:9411

Topics: Adult; Aged; Anticholesteremic Agents; Arterial Occlusive Diseases; Brain Ischemia; Cerebrovascular Disorders; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Female; Humans; Incidence; Male; Middle Aged; Peripheral Nervous System Diseases; Placebos; Simvastatin; Stroke; Treatment Outcome

2004

Other Studies

5 other study(ies) available for simvastatin and Peripheral Nerve Diseases

Article	Year
Identification of prophylactic drugs for oxaliplatin-induced peripheral neuropathy using big data. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 148 Topics: Animals; Anticholesteremic Agents; Antineoplastic Agents; Big Data; Databases, Factual; Drug Repositioning; Humans; Hyperalgesia; Japan; Male; Mice; Mice, Inbred BALB C; Oxaliplatin; Peripheral Nervous System Diseases; Pre-Exposure Prophylaxis; Rats; Rats, Sprague-Dawley; Retrospective Studies; Simvastatin	2022
P-Glycoprotein Inhibition Exacerbates Paclitaxel Neurotoxicity in Neurons and Patients With Cancer. Clinical pharmacology and therapeutics, 2020, Volume: 108, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cyclosporins; Dose-Response Relationship, Drug; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neurons; Paclitaxel; Peripheral Nervous System Diseases; Retrospective Studies; Risk Assessment; Risk Factors; Simvastatin; Verapamil	2020
Statin therapy and small fibre neuropathy: a serial electrophysiological study. Journal of the neurological sciences, 2003, Apr-15, Volume: 208, Issue:1-2 Topics: Anticholesteremic Agents; Electric Stimulation; Electrophysiology; Humans; Hypercholesterolemia; Lower Extremity; Male; Middle Aged; Neural Conduction; Peripheral Nervous System Diseases; Pravastatin; Simvastatin	2003
Cerebrotendinous xanthomatosis: a treatable ataxia. Neurology, 2005, Apr-26, Volume: 64, Issue:8 Topics: Adult; Cerebellar Ataxia; Cerebellum; Chenodeoxycholic Acid; Cholestanol; Cholesterol; Disease Progression; Electroencephalography; Humans; Magnetic Resonance Imaging; Male; Paraparesis, Spastic; Peripheral Nervous System Diseases; Simvastatin; Treatment Outcome; Xanthomatosis, Cerebrotendinous	2005
Peripheral neuropathy associated with simvastatin. Journal of neurology, neurosurgery, and psychiatry, 1995, Volume: 58, Issue:5 Topics: Adult; Aged; Anticholesteremic Agents; Female; Humans; Lovastatin; Male; Middle Aged; Neural Conduction; Peripheral Nervous System Diseases; Reaction Time; Simvastatin	1995